Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | $4.62 | $1.72 | 59.31% | 53.6M | $7.4M | $1.33$21.00 |
| CVGI | Commercial Vehicle Group | $2.24 | $0.62 | 38.27% | 828K | $60M | $0.81$2.89 |
| BODI | Beachbody | $11.11 | $2.78 | 33.37% | 151K | $59M | $3.38$12.66 |
| NBIG | Themes ETF Trust - Leverage Shares 2x Long Nbis Daily ETF | $8.92 | $1.99 | 28.73% | 2.5M | - | $4.51$19.45 |
| NBIL | GraniteShares ETF Trust - GraniteShares 2x Long Nbis Daily ETF | $12.59 | $2.76 | 28.07% | 3.5M | - | $6.37$38.58 |
| ADAG | Adagene | $3.74 | $0.81 | 27.64% | 1.6M | $138M | $1.30$4.58 |
| HIMZ | Tidal Trust II - Defiance Daily Target 2x Long Hims ETF | $2.88 | $0.61 | 26.87% | 65.3M | - | $0.88$55.77 |
| SAGT | Sagtec Global | $2.32 | $0.49 | 26.78% | 930K | $23M | $1.10$6.24 |
| CYN | Cyngn | $2.00 | $0.40 | 24.69% | 38.5M | $13M | $1.33$41.54 |
| OCGN | Ocugen | $2.16 | $0.39 | 22.15% | 26.2M | $580M | $0.52$2.32 |
| ORCX | Tidal Trust II - Defiance Daily Target 2x Long Orcl ETF | $11.39 | $1.94 | 20.55% | 23.8M | - | $8.00$60.53 |
| ORCU | Direxion Shares ETF Trust - Daily Orcl Bull 2x Etf | $12.27 | $2.09 | 20.51% | 2.7M | - | $8.58$27.62 |
| AHG | Akso Health Group | $2.14 | $0.36 | 20.23% | 172.4K | $1.5B | $0.83$2.44 |
| NVTS | Navitas Semiconductor | $10.42 | $1.74 | 19.99% | 26.7M | $2.0B | $1.52$17.79 |
| AUNA | Auna | $5.70 | $0.90 | 18.75% | 1.5M | $355M | $4.46$7.87 |
| VELO | Velo3D | $14.63 | $2.24 | 18.08% | 3.9M | $305M | $1.43$23.84 |
| DOMO | Domo | $5.15 | $0.77 | 17.57% | 19.6M | $183M | $3.45$18.49 |
| SXTP | 60 Degrees Pharmaceuticals | $2.21 | $0.33 | 17.55% | 13.4M | $2.0M | $1.36$17.68 |
| CRWG | Themes ETF Trust - Leverage Shares 2x Long Crwv Daily ETF | $2.77 | $0.41 | 17.37% | 27.9M | - | $2.09$19.63 |
| DCBO | Docebo | $21.91 | $3.21 | 17.17% | 13K | $538M | $16.07$33.70 |
| IREG | Themes ETF Trust - Leverage Shares 2x Long Iren Daily ETF | $14.76 | $2.12 | 16.77% | 153.2K | - | $11.23$41.60 |
| IXHL | Incannex Healthcare | $5.85 | $0.84 | 16.77% | 22.9K | $58M | $2.40$49.80 |
| ACTG | Acacia Research | $4.82 | $0.67 | 16.14% | 1.1M | $400M | $2.70$5.07 |
| HIMS | Hims & Hers Health | $26.80 | $3.33 | 14.19% | 2.1M | $5.3B | $13.74$70.43 |
| MLAB | Mesa Laboratories | $83.47 | $10.24 | 13.98% | 3.3K | $405M | $55.45$131.20 |
| APYX | Apyx Medical | $3.92 | $0.47 | 13.59% | 313.8K | $142M | $0.76$4.50 |
| NUAI | New Era Energy & Digital | $5.10 | $0.59 | 12.97% | 2.2M | $242M | $0.32$9.45 |
| UPB | Upstream Bio | $9.16 | $1.04 | 12.81% | 580.9K | $439M | $5.14$33.68 |
| TURB | Turbo Energy | $3.80 | $0.33 | 9.51% | 1.4M | $38M | $0.57$20.45 |
| SSII | Ss Innovations International | $4.83 | $0.41 | 9.28% | 548 | $856M | $3.02$22.42 |
| METCZ | Ramaco Resources | $25.40 | -$0.05 | -0.20% | 46 | - | $23.18$26.00 |
Related Articles
Featured Article
Navitas Just Unveiled AI Data Center Technology Investors Need to See
Rick Orford|Mar 11, 2026
Navitas just revealed technology targeting one of the biggest hidden bottlenecks in the AI boom, and the implications for NVTS stock could surprise investors.
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
Geoffrey Seiler|Mar 9, 2026
Hims & Hers stock traded more than 40% higher after the deal was announced.
Hims & Hers Stock Pops 40%: Everything You Need to Know
Travis Hoium|Mar 9, 2026
Hims & Hers shares are up over 40% on Monday after announcing a deal with Novo Nordisk.
Down 70% Over the Past Year, Can Hims & Hers Health Stock Bounce Back?
Geoffrey Seiler|Feb 27, 2026
The company is looking toward international markets to boost its growth.
Should You Buy Navitas Semiconductor Stock Now?
John Ballard|Feb 24, 2026
The company's data center opportunity is enormous, but this is well reflected in the stock's valuation.
Where Will Navitas Semiconductor Be in 5 Years?
Micah Zimmerman|Feb 20, 2026
This stock is a high-risk, high-upside AI infrastructure play focused on making power delivery in chips more efficient.
Hims & Hers HUGE Acquisition News!
Travis Hoium|Feb 19, 2026
Hims & Hers is acquiring Eucalyptus and spreading its wings internationally.
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
Bram Berkowitz|Feb 9, 2026
Hims & Hers could face difficulty in the future in selling copycat GLP-1 drugs.
Hims & Hers Takes On Novo Nordisk: What We Know Right Now
Travis Hoium|Feb 5, 2026
Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.
HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
Travis Hoium|Feb 4, 2026
Hims & Hers is moving beyond prescriptions to preventative testing.
